CY1106550T1 - Διαδικασια για την παρασκευη σωματιδιων - Google Patents
Διαδικασια για την παρασκευη σωματιδιωνInfo
- Publication number
- CY1106550T1 CY1106550T1 CY20071100570T CY071100570T CY1106550T1 CY 1106550 T1 CY1106550 T1 CY 1106550T1 CY 20071100570 T CY20071100570 T CY 20071100570T CY 071100570 T CY071100570 T CY 071100570T CY 1106550 T1 CY1106550 T1 CY 1106550T1
- Authority
- CY
- Cyprus
- Prior art keywords
- liquid
- particles
- temperature
- substance
- buffer
- Prior art date
Links
- 239000002245 particle Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 239000007788 liquid Substances 0.000 abstract 7
- 239000000126 substance Substances 0.000 abstract 3
- 239000012530 fluid Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 239000012296 anti-solvent Substances 0.000 abstract 1
- 230000007423 decrease Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/04—Solvent extraction of solutions which are liquid
- B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
- B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Μία διαδικασία για την παρασκευή σωματιδίων μίας ουσίας, όπως μία πρωτείνη ή πολυπεπτίδιο, που περιλαμβάνει: (α) παρασκευή ενός πρώτου υγρού που περιλαμβάνει νερό, την ουσία κι ένα ρυθμιστή, όπου ο ρυθμιστής έχει μία διαλυτότητα στο νερό η οποία ελαττώνεται καθώς αυξάνεται η θερμοκρασία· και (β) επαφή του πρώτου υγρού μ' ένα δεύτερο υγρό που περιλαμβάνει ένα ρευστό αέριο κι έναν οργανικό διαλύτη χρησιμοποιώντας μία τεχνική ρευστού αερίου αντι-διαλύτη (anti-solvent fluid gas technique) υπό συνθήκες θερμοκρασίας και πίεσης που καταλήγουν στην καθίζηση σωματιδίων που περιλαμβάνουν την ουσία, όπου η θερμοκρασία του πρώτου υγρού είναι η θερμοκρασία σημείου θόλωσης του πρώτου υγρού ή πάνω από αυτή όταν το πρώτο υγρό έρχεται σ' επαφή με το δεύτερο υγρό. Επίσης αξιώνονται σωματίδια που προκύπτουν σύμφωνα με τη διαδικασία και οι συνθέσεις που περιέχουν τα σωματίδια.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0102075.9A GB0102075D0 (en) | 2001-01-26 | 2001-01-26 | Process |
PCT/GB2002/000261 WO2002058674A2 (en) | 2001-01-26 | 2002-01-22 | Process for preparing particles |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1106550T1 true CY1106550T1 (el) | 2012-01-25 |
Family
ID=9907591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20071100570T CY1106550T1 (el) | 2001-01-26 | 2007-04-26 | Διαδικασια για την παρασκευη σωματιδιων |
Country Status (22)
Country | Link |
---|---|
US (2) | US7108867B2 (el) |
EP (1) | EP1357901B1 (el) |
JP (1) | JP4175892B2 (el) |
KR (1) | KR100853596B1 (el) |
CN (1) | CN1298312C (el) |
AT (1) | ATE354352T1 (el) |
BR (1) | BR0206439A (el) |
CA (1) | CA2433838A1 (el) |
CY (1) | CY1106550T1 (el) |
DE (1) | DE60218285T2 (el) |
DK (1) | DK1357901T3 (el) |
ES (1) | ES2281509T3 (el) |
GB (1) | GB0102075D0 (el) |
HK (1) | HK1063157A1 (el) |
IL (2) | IL156720A0 (el) |
MX (1) | MXPA03006537A (el) |
NO (1) | NO20033241L (el) |
NZ (1) | NZ526942A (el) |
PT (1) | PT1357901E (el) |
SI (1) | SI1357901T1 (el) |
WO (1) | WO2002058674A2 (el) |
ZA (1) | ZA200304953B (el) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0027357D0 (en) | 2000-11-09 | 2000-12-27 | Bradford Particle Design Plc | Particle formation methods and their products |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
GB0126716D0 (en) * | 2001-11-07 | 2002-01-02 | Advanced Phytonics Ltd | Method for the production of particles |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
US20040197412A1 (en) * | 2002-12-19 | 2004-10-07 | Baxter International, Inc. | Process for preparing pharmaceutical formulations using supercritical fluids |
DE602004016311D1 (de) * | 2003-04-29 | 2008-10-16 | Organon Nv | Verfahren zur verfestigung, bei welchem ein anti-lösungsmittel benutzt wird |
JP2006525303A (ja) | 2003-05-08 | 2006-11-09 | ネクター セラピューティクス ユーケー リミティド | 微粒子物質 |
JP2007507527A (ja) * | 2003-09-30 | 2007-03-29 | スフェリックス, インコーポレイテッド | 生物学的に活性なナノ粒子治療用因子 |
US7223445B2 (en) | 2004-03-31 | 2007-05-29 | Eastman Kodak Company | Process for the deposition of uniform layer of particulate material |
US7220456B2 (en) | 2004-03-31 | 2007-05-22 | Eastman Kodak Company | Process for the selective deposition of particulate material |
WO2007009164A1 (en) | 2005-07-15 | 2007-01-25 | Eiffel Technologies Limited | Method of particle formation |
NL1031224C2 (nl) * | 2006-02-23 | 2007-09-03 | Friesland Brands Bv | Het bereiden van gedroogde deeltjes met behulp van een superkritisch medium. |
EP2121057A4 (en) * | 2007-02-06 | 2012-10-10 | Incept Llc | POLYMERIZATION WITH PRECIPITATION OF PROTEINS FOR ELUTION IN A PHYSIOLOGICAL SOLUTION |
HUE026884T2 (en) | 2007-02-11 | 2016-08-29 | Map Pharmaceuticals Inc | DHE is a therapeutic method of administration for the rapid relief of migraine while minimizing side effects |
JP5307382B2 (ja) * | 2007-11-14 | 2013-10-02 | 日機装株式会社 | 微粒子化方法 |
EP2229233B1 (en) * | 2007-12-07 | 2019-10-09 | XSpray Pharma AB (publ) | Method for the production of particles |
CA2767773C (en) | 2011-02-11 | 2015-11-24 | Grain Processing Corporation | Composition comprising a salt and a crystallization interrupter |
EP4324475A1 (en) * | 2012-03-22 | 2024-02-21 | Novo Nordisk A/S | Compositions of glp-1 peptides and preparation thereof |
JP6668652B2 (ja) | 2015-09-18 | 2020-03-18 | 日本精工株式会社 | 直動案内装置、直動案内装置用エンドキャップ |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0432232T3 (da) | 1989-05-01 | 1994-01-31 | Alkermes Inc | Fremgangsmåde til fremstilling af små partikler af biologisk aktive molekyler |
US5639441A (en) | 1992-03-06 | 1997-06-17 | Board Of Regents Of University Of Colorado | Methods for fine particle formation |
US5346702A (en) * | 1992-12-04 | 1994-09-13 | Sterling Winthrop Inc. | Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
GB9313642D0 (en) | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
GB9413202D0 (en) | 1994-06-30 | 1994-08-24 | Univ Bradford | Method and apparatus for the formation of particles |
CA2234957C (en) | 1995-10-17 | 2006-12-19 | Inge B. Henriksen | Insoluble drug delivery |
GB9703673D0 (en) | 1997-02-21 | 1997-04-09 | Bradford Particle Design Ltd | Method and apparatus for the formation of particles |
GB9804379D0 (en) | 1998-03-02 | 1998-04-22 | Bradford Particle Design Ltd | Method of particle formation |
AU3705799A (en) * | 1998-04-09 | 1999-11-01 | F. Hoffmann-La Roche Ag | Process for the manufacture of (sub)micron sized particles by dissolving in compressed gas and surfactants |
SE9801287D0 (sv) | 1998-04-14 | 1998-04-14 | Astra Ab | Incorporation of active substances in carrier matrixes |
GB9810559D0 (en) | 1998-05-15 | 1998-07-15 | Bradford Particle Design Ltd | Method and apparatus for particle formation |
SE9804001D0 (sv) | 1998-11-23 | 1998-11-23 | Astra Ab | New process |
GB9828204D0 (en) | 1998-12-21 | 1999-02-17 | Smithkline Beecham Plc | Process |
GB9915975D0 (en) | 1999-07-07 | 1999-09-08 | Bradford Particle Design Ltd | Method for the formation of particles |
GB9920558D0 (en) | 1999-08-31 | 1999-11-03 | Bradford Particle Design Ltd | Methods for particle formation and their products |
EP1404438A2 (en) * | 2001-07-12 | 2004-04-07 | Eastman Kodak Company | A surfactant assisted nanomaterial generation process |
US6998051B2 (en) * | 2002-07-03 | 2006-02-14 | Ferro Corporation | Particles from supercritical fluid extraction of emulsion |
WO2005055983A2 (en) * | 2003-12-09 | 2005-06-23 | Medcrystalforms, Llc | Method of preparation of mixed phase co-crystals with active agents |
US7754243B2 (en) * | 2004-08-03 | 2010-07-13 | Clemson University Research Foundation | Aqueous suspension of nanoscale drug particles from supercritical fluid processing |
-
2001
- 2001-01-26 GB GBGB0102075.9A patent/GB0102075D0/en not_active Ceased
-
2002
- 2002-01-21 US US10/250,868 patent/US7108867B2/en not_active Expired - Fee Related
- 2002-01-21 BR BR0206439-1A patent/BR0206439A/pt not_active IP Right Cessation
- 2002-01-21 CN CNB028041011A patent/CN1298312C/zh not_active Expired - Fee Related
- 2002-01-21 IL IL15672002A patent/IL156720A0/xx unknown
- 2002-01-21 MX MXPA03006537A patent/MXPA03006537A/es active IP Right Grant
- 2002-01-21 SI SI200230521T patent/SI1357901T1/sl unknown
- 2002-01-21 PT PT02715546T patent/PT1357901E/pt unknown
- 2002-01-22 EP EP02715546A patent/EP1357901B1/en not_active Expired - Lifetime
- 2002-01-22 DK DK02715546T patent/DK1357901T3/da active
- 2002-01-22 AT AT02715546T patent/ATE354352T1/de not_active IP Right Cessation
- 2002-01-22 ES ES02715546T patent/ES2281509T3/es not_active Expired - Lifetime
- 2002-01-22 DE DE60218285T patent/DE60218285T2/de not_active Expired - Lifetime
- 2002-01-22 JP JP2002559008A patent/JP4175892B2/ja not_active Expired - Fee Related
- 2002-01-22 NZ NZ526942A patent/NZ526942A/xx unknown
- 2002-01-22 KR KR1020037009726A patent/KR100853596B1/ko not_active IP Right Cessation
- 2002-01-22 CA CA002433838A patent/CA2433838A1/en not_active Abandoned
- 2002-01-22 WO PCT/GB2002/000261 patent/WO2002058674A2/en active IP Right Grant
-
2003
- 2003-06-25 ZA ZA200304953A patent/ZA200304953B/en unknown
- 2003-06-30 IL IL156720A patent/IL156720A/en not_active IP Right Cessation
- 2003-07-17 NO NO20033241A patent/NO20033241L/no not_active Application Discontinuation
-
2004
- 2004-08-09 HK HK04105963A patent/HK1063157A1/xx not_active IP Right Cessation
-
2006
- 2006-09-15 US US11/521,631 patent/US7829123B2/en not_active Expired - Fee Related
-
2007
- 2007-04-26 CY CY20071100570T patent/CY1106550T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CN1298312C (zh) | 2007-02-07 |
EP1357901A2 (en) | 2003-11-05 |
NO20033241D0 (no) | 2003-07-17 |
ZA200304953B (en) | 2004-08-25 |
CN1487825A (zh) | 2004-04-07 |
DE60218285T2 (de) | 2007-11-15 |
KR20030070921A (ko) | 2003-09-02 |
KR100853596B1 (ko) | 2008-08-22 |
PT1357901E (pt) | 2007-05-31 |
JP2004521891A (ja) | 2004-07-22 |
ES2281509T3 (es) | 2007-10-01 |
ATE354352T1 (de) | 2007-03-15 |
WO2002058674A3 (en) | 2002-11-21 |
EP1357901B1 (en) | 2007-02-21 |
WO2002058674A2 (en) | 2002-08-01 |
CA2433838A1 (en) | 2002-08-01 |
US20070009604A1 (en) | 2007-01-11 |
IL156720A (en) | 2010-03-28 |
AU2002225193B2 (en) | 2006-07-27 |
DK1357901T3 (da) | 2007-06-04 |
IL156720A0 (en) | 2004-01-04 |
US7108867B2 (en) | 2006-09-19 |
DE60218285D1 (de) | 2007-04-05 |
US20040058007A1 (en) | 2004-03-25 |
HK1063157A1 (en) | 2004-12-17 |
GB0102075D0 (en) | 2001-03-14 |
NZ526942A (en) | 2005-04-29 |
BR0206439A (pt) | 2003-12-30 |
JP4175892B2 (ja) | 2008-11-05 |
MXPA03006537A (es) | 2003-09-22 |
SI1357901T1 (sl) | 2007-08-31 |
US7829123B2 (en) | 2010-11-09 |
NO20033241L (no) | 2003-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106550T1 (el) | Διαδικασια για την παρασκευη σωματιδιων | |
CY1117625T1 (el) | Διαλυτα μεταλλαγμενα μορια ctla4 και χρησεις αυτων | |
CY1113684T1 (el) | Anti-mikρobiaka πεπτιδια που περιλαμβανουν μια αργινινη (arginine)- kai/ή λυσινη (lysine)- που περιεχουν υποκινητη | |
Machold et al. | Resolution of the light-harvesting chlorophyll ab-protein of Vicia faba chloroplasts into two different chlorophyll-protein complexes | |
ATE533514T1 (de) | Verzweigtes polyethylen-glykol zur verknüpfung von polymerresten mit antikörpern | |
BR0113921A (pt) | ácidos nucléicos e polipeptìdeos receptores | |
CY1113512T1 (el) | Διαταξη περιλαμβανουσα ενα ηλεκτροδιο με νανοεπικαλυψη για την παρασκευη ενος πολυ σταθερου υδατικου διαλυματος και μεθοδος παραγωγης αυτου του υδατικου διαλυματος | |
HUP9801400A2 (hu) | Poli-szukcinimid előállítása szerves közegben | |
ZA200201032B (en) | Monomeric protein of the TG-β family. | |
ES2144399T3 (es) | Clonado del adn de virus de anemia de los pollos. | |
OHNISHI et al. | Extraction of actin-and myosin-like proteins from liver mitochondria | |
ATE386821T1 (de) | Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2) | |
DE69224988D1 (de) | Aminosäurederivat und bromacetyl-modifizierte peptide | |
DK1465663T3 (da) | Brugsfærdige paracetamol-injektionsoplösninger som indeholder propylenglycol som det eneste CO-oplösningsmiddel | |
WO2005014723A8 (en) | Cyanin-type compounds having an alkynyl linker arm | |
CY1109244T1 (el) | Νευρολοιμογονο στελεχος του ιου δυτικου νειλου και εφαρμογες αυτου. | |
BR0108791A (pt) | Composto cìclico, processo para sua preparação, composição farmacêutica, seu uso e embalagem comercial | |
ATE255921T1 (de) | Keramic-polymer-zusammensetzungen | |
Yang et al. | Bioinspired Load‐Bearing Hydrogel Based on Engineered Sea Anemone Skin‐Derived Collagen‐Like Protein | |
DE60229966D1 (de) | Diabetesmodell | |
ES387966A1 (es) | Procedimiento para componer preparaciones estables de pro- ductos de reaccion solubles o dispersables en agua. | |
DE60109212D1 (de) | Herstellung von warfarin-natrium aus warfarin-säure | |
KR830009077A (ko) | 푸란 유도체의 제조방법 | |
ATE439343T1 (de) | Verbessertes verfahren zur zubereitung von gabalactam | |
ATE524484T1 (de) | In vitro verfahren zur sequenzspezifischen biotinylierung von polypeptiden |